Overview
- Researchers reported on September 25, 2026, that ischemic stroke accelerates glioma infiltration and shortens survival in human and mouse models.
- The team found a new population of tumor-associated astrocytes (TAAs) with reduced calcium (Ca2+) activity that appears in injured brain regions.
- Stroke also increased tumor-associated microglia and macrophages (TAMs) through CCL2-driven recruitment, changing the tumor microenvironment in ways that favor tumor growth.
- Mechanistic experiments identified SLC4A4 as a regulator of TAA Ca2+ activity and showed that restoring astrocyte Ca2+ signaling or depleting TAMs suppressed stroke-driven tumor progression in preclinical models.
- The findings move a decades-old epidemiological link from correlation toward testable biology and point to SLC4A4, CCL2, TAAs, and TAMs as candidate targets, but the results are preclinical and need validation before any clinical use.